Johnson & Johnson (JNJ) is listed among the 10 Best Recession Proof Dividend Stocks to Buy due to its stability and long history of dividend payments. With a diverse portfolio and 63 consecutive years of dividend increases, JNJ is well-positioned for long-term success, even during economic downturns.

Founded in 1886, Johnson & Johnson has evolved into a global pharmaceutical and medical device giant with a diverse product portfolio. Unlike some competitors, JNJ’s earnings are less affected by patent expirations, thanks to its broad range of treatments and devices.

Despite potential dips in demand for medical devices during recessions, Johnson & Johnson’s essential treatments ensure continued stability. With a quarterly dividend of $1.30 per share and a yield of 2.89%, JNJ is a reliable choice for investors seeking recession-resistant stocks.

While Johnson & Johnson offers stability and consistent dividends, some AI stocks may offer greater upside potential and lower risk. Investors seeking undervalued AI opportunities can explore other options while still benefiting from JNJ’s solid performance.

For more insights on dividend stocks in different sectors, check out articles on telecom, NYSE, and bank dividend stocks. Remember to consider all factors before making investment decisions.

Read more at Yahoo Finance: A Dividend Aristocrat With Unmatched Stability